The Mulligan Law Firm is Evaluating Reglan® Injury Cases and Tardive dyskinesia

The Mulligan Law Firm is Evaluating Reglan® Injury Cases and Tardive dyskinesia The Mulligan Law Firm announces that it is evaluating and investigating cases where usage of the prescription drug Reglan® has led to the development of a serious condition called Tardive dyskinesia. Dallas, TX (PRWEB) April 19, 2009 -- The Mulligan Law Firm (http://www.mulliganlaw.com) has started evaluating possible Reglan® injury claims and links with the development of a serious side-effect: Tardive dyskinesia. Reglan® (which has the generic na
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations